Pancreatic cancer treatment may be aided by the discovery of a new hereditary cause of the
Scientists at Johns Hopkins in the US have found that a mutation in the ATM
gene may increase the risk of patients developing tumours in the pancreas.
Doctors explained that the findings are significant as ten per cent of
incidences occur in those with a family history of the illness.
"There was significant reason to believe this clustering was due to
genetics, but we had not, to this point, been able to find the causative,"
said lead author Alison Klein, associate professor of oncology at the Sidney
Kimmel Comprehensive Cancer Center at Johns Hopkins.
She and her colleagues used the latest diagnostic imaging equipment to
sequence whole genomes before they could isolate the ATM gene.
According to Cancer Research UK, pancreatic cancer is the tenth most common
form of the disease in the UK and only three per cent of people diagnosed
survive more than five years.
© Adfero Ltd
Cancer treatment news : 31 December 2011